Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Natalie Morgenstern"'
Autor:
Scott Kinlay, Lien Quach, Jean Cormack, Natalie Morgenstern, Ying Hou, Melissa Young, Rebecca Sherrod, Kelly Cho, David P. Faxon, Ronnie Ramadan, Michael Gaziano, David Gagnon
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 9 (2021)
Background Premature discontinuation of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention is related to higher short‐term risks of adverse outcomes. Whether these risks persist in the long‐term is uncertain. Methods and Re
Externí odkaz:
https://doaj.org/article/469a59e30b3747cdb1f69cbb9b570e6d
Autor:
Kelly M. Harrington, Matthew H. Liang, Keri Hannagan, Soe Soe Thwin, Ryan E. Ferguson, Natalie Morgenstern, Erick Flores, Ira R. Katz
Publikováno v:
Contemporary Clinical Trials Communications, Vol 4, Iss C, Pp 149-154 (2016)
Background: The estimation of an effect size is an important step in designing an adequately powered, feasible clinical trial intended to change clinical practice. During the planning phase of VA Cooperative Study #590, “Double-Blind Placebo-Contro
Externí odkaz:
https://doaj.org/article/abb60b29ba7640768245296dda0149f6
Autor:
Blake Cutler, Nilushi Minoli Dediwalage, Natalie Morgenstern, Rebecca Rosenberg, Melissa Mackie, Oskar Bleeker, Mandy Salisbury, Gitaa Nyasani
Publikováno v:
Research and Teaching in a Pandemic World ISBN: 9789811977565
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f4549ff69382449dec5be08e1a095d4
https://doi.org/10.1007/978-981-19-7757-2_8
https://doi.org/10.1007/978-981-19-7757-2_8
Autor:
Jean Cormack, Scott Kinlay, David P. Faxon, Rebecca Sherrod, David R. Gagnon, Michael Gaziano, Ronnie Ramadan, Natalie Morgenstern, Kelly Cho, Ying Hou, Melissa M. Young, Lien Quach
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Premature discontinuation of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention is related to higher short‐term risks of adverse outcomes. Whether these risks persist in the long‐term is uncertain. Methods and Re
Autor:
Erick Flores, Keri Hannagan, Natalie Morgenstern, Ryan Ferguson, Matthew H. Liang, Soe Soe Thwin, Ira R. Katz, Kelly M. Harrington
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 4, Iss C, Pp 149-154 (2016)
Contemporary Clinical Trials Communications, Vol 4, Iss C, Pp 149-154 (2016)
Background The estimation of an effect size is an important step in designing an adequately powered, feasible clinical trial intended to change clinical practice. During the planning phase of VA Cooperative Study #590, “Double-Blind Placebo-Control